GHRP-6 10 MG

Dragon Pharma GHRP-6

GHRP-6 10 mg provides a substantial research dose of the pioneering hexapeptide (His-D-Trp-Ala-Trp-D-Phe-Lys-NH₂) that revolutionized growth hormone research as the first synthetic Growth Hormone Releasing Peptide. Discovered in the 1980s, GHRP-6 functions as a potent ghrelin receptor (GHS-R1a) agonist, mimicking the action of the natural "hunger hormone" ghrelin to stimulate powerful, pulsatile releases of growth hormone (GH) from the anterior pituitary gland. Its mechanism involves both direct pituitary stimulation and suppression of somatostatin—the primary inhibitor of GH secretion. What distinguishes GHRP-6 in research is its pronounced effect on appetite stimulation, mediated through the same ghrelin receptor pathway in the hypothalamus, making it uniquely valuable for studies where increased food intake is a desired outcome alongside GH elevation.

For bodybuilders, athletes, and medical researchers in the USA, Dragon Pharma GHRP-6 10 mg offers dual-action research capabilities ideal for bulking phases, cachexia studies, and conditions requiring both anabolic stimulation and appetite enhancement. Research focuses on its potential to significantly increase lean body mass through enhanced protein synthesis, improve nitrogen retention, accelerate recovery from training or injury, and promote substantial increases in caloric intake. The 10 mg concentration is particularly suitable for extended research cycles where daily or multiple-daily administration is required. Beyond muscle growth, GHRP-6 is studied for its effects on connective tissue repair, sleep quality improvement (via GH-mediated effects), and potential neuroprotective properties. Manufactured by Dragon Pharma under stringent quality control in certified European facilities, this vial ensures researchers receive a pure, potent peptide for comprehensive endocrine and metabolic studies.

Key Benefits:

• Powerful GH Release & Appetite Stimulation: Dual-action peptide that significantly increases growth hormone levels while strongly stimulating hunger via ghrelin receptor agonism.
• Ideal for Bulking & Mass Building Research: Creates an optimal anabolic environment through increased GH/IGF-1 while promoting substantial caloric intake for mass accretion studies.
• Enhanced Recovery & Connective Tissue Repair: Research focuses on accelerated healing of muscles, tendons, and ligaments through increased collagen synthesis and anti-inflammatory effects.
• Improved Sleep Quality: May enhance deep sleep stages (when natural GH peaks) through its GH-releasing properties, supporting recovery research.
• High-Concentration Research Formula: 10 mg per vial provides ample material for extended daily administration protocols and combination studies.

Each 2 mL vial contains 10 mg of high-purity GHRP-6 hexapeptide as a sterile lyophilized powder, synthesized using advanced solid-phase peptide synthesis under Dragon Pharma's pharmaceutical-grade quality standards.

Product Specifications

Usage Guidelines

Research Application Only: This information summarizes scientific literature for educational context. Dragon Pharma GHRP-6 10 mg is a research chemical for laboratory investigation, not for human consumption.

In experimental settings, GHRP-6 is reconstituted with bacteriostatic water. Research protocols typically utilize subcutaneous administration. To maximize both GH release and appetite stimulation, studies often time administrations 15-30 minutes before planned meals (typically 2-3 times daily). The pre-meal timing leverages the peptide's hunger-inducing effects while ensuring nutrients are available for the anabolic window created by GH release. Administration on an empty stomach enhances effectiveness. Research cycles are typically 8-12 weeks with 4-week breaks to prevent receptor desensitization. Studies may monitor not only body composition but also food intake measurements, gastric emptying rates, and subjective hunger ratings.

• Bulking & Mass Accretion Research (8-12 weeks): 2-3 daily pre-meal administrations to study effects on lean mass gain, appetite, nitrogen balance, and overall anabolic status.
• Cachexia & Muscle Wasting Studies (12+ weeks): Extended protocols focusing on reversing catabolic states, improving nutritional status, and increasing body weight in wasting models.

Post Cycle Therapy (PCT):

As a GH secretagogue, GHRP-6 does not suppress the HPTA, so traditional PCT with SERMs like Nolvadex is not applicable. The research consideration is managing potential rebound effects on appetite and maintaining gains. A 4-week minimum break between cycles is standard for receptor recovery. Some protocols incorporate natural appetite support or transition to MK-677 (Ibutamoren) for continued GH stimulation without the strong hunger effects. For maintaining anabolic status, 1-Test Cyp could be studied in follow-up protocols.

Synergistic Research Combinations:

GHRP-6 is frequently studied alongside other compounds. For maximal mass building research, it pairs powerfully with androgens like Dianabol 50 for synergistic anabolic effects. With GHRH analogs like CJC-1295 DAC, it creates comprehensive GH stimulation. For appetite and digestion optimization, combining with GLOW (digestive support) could be explored. In recovery studies, pairing with BPC-157 may enhance tissue repair. For nutrient partitioning research, related compounds could be included in study designs.

Third-Party Lab Tested

2025-11-07

View Result

10.38 mg

Lab Analysis Note: The November 2025 third-party HPLC test confirms 10.38 mg of GHRP-6 peptide per vial—103.8% of the labeled 10 mg. This overfill demonstrates Dragon Pharma's commitment to premium research products. Mass spectrometry verifies the correct hexapeptide sequence (His-D-Trp-Ala-Trp-D-Phe-Lys-NH₂) with ≥98% purity, ensuring researchers receive a potent, accurately dosed compound for GH and appetite studies.

Storage Instructions

Proper storage is essential to maintain the stability and potency of this research peptide.

• Unreconstituted Powder: Store the sealed vial in a freezer at -20°C (-4°F) or colder for long-term stability. In this lyophilized state, GHRP-6 remains stable for up to 24 months. Protect from light and moisture, and avoid repeated freeze-thaw cycles.
• After Reconstitution: Once reconstituted with bacteriostatic water, the solution must be refrigerated immediately at 2°C to 8°C (36°F to 46°F). The reconstituted solution is typically stable for research use for 3-4 weeks when refrigerated. For best results in pre-meal dosing studies, use within 21 days. Never freeze the liquid solution.
• Important for Appetite Research: Since studies often use pre-meal timing, ensure the reconstituted peptide is readily accessible during feeding periods. Proper labeling and organization are crucial for multi-dosing protocols common in appetite and feeding behavior research.